CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Dario Blood Glucose Monitoring System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04057248
NCT04057248N/ACompleted

Digital Self-Management and Health Coaching for Type 2 Diabetes - Impact on Diabetes Clinical and Wellness Indicators

LabStyle Innovations Ltd.·interventional·Posted Aug 15, 2019·Updated Jun 4, 2021

In Brief

A clinical study evaluating Dario Blood Glucose Monitoring System and CDE for Diabetes Mellitus, Type 2. Completed, enrolled 14 participants across 1 site.

Detailed Summary

Each subject enrolled in the study will be requested to complete an intake questionnaire including diabetes quality of life questions. The subject will use Dario Blood glucose monitoring system and will be contacted by a Certified Diabetes Educator (CDE) two to three times a month as well as have a direct communication using other communication channels such as mail, chat and text messaging (SMS) for lifestyle and diabetes management coaching for a total duration of three months. In the end of study, the subject will complete a diabetes quality of life questionnaire and have a blood test to evaluate its clinical parameters.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 15, 2019
Enrollment StartJul 9, 2018
Primary CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.9 years ago

Interventions

Dario Blood Glucose Monitoring Systemdevice

Dario Blood Glucose Monitoring System (BGMS) with Dario App and Dario digital platform

CDEbehavioral

Certified Diabetes Educator Sessions